Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Terrascend Corp T.TSND

Alternate Symbol(s):  TSNDF

TerrAscend Corp. is a Canada-based cannabis company. The Company provides cannabis products, brands, and services to the United States and Canadian cannabinoid markets. It operates in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. (TerrAscend Growth) and retail operations in Canada. The Company operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. It also operates Peninsula Alternative Health, a medical dispensary in Maryland. The Company owns or licenses several synergistic businesses and brands, including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, and Valhalla Confections. Ilera Healthcare is a medical cannabis cultivator, processor and dispenser with operations in New Jersey. Valhalla Confections is a manufacturer of cannabis-infused edibles.


TSX:TSND - Post by User

Post by Betteryear2on Nov 09, 2023 6:19pm
133 Views
Post# 35727194

TerrAscend Reports Record Third Quarter 2023 Results

TerrAscend Reports Record Third Quarter 2023 Results

Net Revenue of $89.2 million, an increase of 34.7% year-over-year and 23.7% sequentially

Gross Profit margin of 53.6%, a 340-basis point sequential improvement from 50.2% in Q2 2023

Adjusted EBITDA from continuing operations1 of $24.2 million, an increase of 89% sequentially, representing a 27.1% Adjusted EBITDA margin1

Increased 2023 guidance for Net Revenue and Adjusted EBITDA from continuing operations1 to $320 million and $73 million versus previous guidance of at least $317 million and $63 million, representing 29% and 87% year-over-year growth, respectively

2023 guidance implies Q4 Net Revenue of $89 million and Adjusted EBITDA from continuing operations1 of $24 million

TORONTO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today reported its financial results for the third quarter ended September 30, 2023. All amounts are expressed in U.S. dollars and are prepared under U.S. Generally Accepted Accounting Principles (GAAP), unless indicated otherwise.

TerrAscend Reports Record Third Quarter 2023 Results and (globenewswire.com)

<< Previous
Bullboard Posts
Next >>